Dechra Pharmaceuticals PLCDPH:LSE

802.56
8.56 / 1.08%
7.59k
17.33%
0.2937
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 28 2014 10:39 GMT.

Summary

As of last trade Dechra Pharmaceuticals PLC (DPH:LSE) traded at 802.56, 2.90% below its 52-week high of 826.50, set on Nov 26, 2014.

52-week range
Today
655.00
Apr 23 2014
826.50
Nov 26 2014
Markit short selling activity
Low
Medium
High
Open814.00
Day high814.00
Day low799.00
Bid797.00
Offer799.50
Previous close794.00
Average volume132.77k
Shares outstanding87.88m
Free float85.00m
P/E (TTM)35.85
Market cap697.80m GBP
EPS (TTM)0.2215 GBP
Annual div (TTM)15.40 GBX
Annual div yield (TTM)1.94%
Div ex-dateNov 06 2014
Div pay-dateNov 21 2014
Last IC View
The last IC recommendation on Dechra Pharmaceuticals PLC shares was Hold at 743.00 on 08 Sep 2014
Read the full article
Data delayed at least 15 minutes, as of Nov 28 2014 10:39 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Dechra Pharmaceuticals PLC+2.24%+6.30%+15.48%+17.33%+88.38%
FTSE 100 Index-1.07%+4.32%-2.43%+0.36%+27.31%
Data delayed at least 15 minutes, as of Nov 28 2014 10:39 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.